Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- -- Peter ...

This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

The company's stock value has tanked before - it was once worth $1 billion.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK, ...

This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...

A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider ...

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, ...